Header Logo

Connection

DAVID S FOLLOWILL to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications DAVID S FOLLOWILL has written about Clinical Trials, Phase I as Topic.
DAVID S FOLLOWILL
Connection Strength
0.027
Clinical Trials, Phase I as Topic
  1. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e291-e298.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.